Related references
Note: Only part of the references are listed.Network Pharmacology and bioinformatics analyses identify intersection genes of niacin and COVID-19 as potential therapeutic targets
Rong Li et al.
BRIEFINGS IN BIOINFORMATICS (2021)
Targeting metabolic dysregulation for fibrosis therapy
Xiao Zhao et al.
NATURE REVIEWS DRUG DISCOVERY (2020)
Global, regional, and national burden of chronic kidney disease, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017
Boris Bikbov et al.
LANCET (2020)
A bioinformatics and network pharmacology approach to the mechanisms of action of Shenxiao decoction for the treatment of diabetic nephropathy
Xin Mou et al.
PHYTOMEDICINE (2020)
HUANGKUISIWUFANG inhibits pyruvate dehydrogenase to improve glomerular injury in anti-Thy1 nephritis model
Ting Lu et al.
JOURNAL OF ETHNOPHARMACOLOGY (2020)
A network pharmacology approach to investigating the mechanism of Tanshinone IIA for the treatment of liver fibrosis
Miao-Juan Shi et al.
JOURNAL OF ETHNOPHARMACOLOGY (2020)
Astragaloside IV acts through multi-scale mechanisms to effectively reduce diabetic nephropathy
Enyu Wang et al.
PHARMACOLOGICAL RESEARCH (2020)
Preliminary study on the anti-apoptotic mechanism of Astragaloside IV on radiation-induced brain cells
Xin Liu et al.
INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY (2020)
From single drug targets to synergistic network pharmacology in ischemic stroke
Ana I. Casas et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
RIPK3 promotes kidney fibrosis via AKT-dependent ATP citrate lyase
Mitsuru Imamura et al.
JCI INSIGHT (2018)
MalaCards: an amalgamated human disease compendium with diverse clinical and genetic annotation and structured search
Noa Rappaport et al.
NUCLEIC ACIDS RESEARCH (2017)
STITCH 5: augmenting protein-chemical interaction networks with tissue and affinity data
Damian Szklarczyk et al.
NUCLEIC ACIDS RESEARCH (2016)
TGF-β: the master regulator of fibrosis
Xiao-ming Meng et al.
NATURE REVIEWS NEPHROLOGY (2016)
Astragalus membranaceus ameliorates renal interstitial fibrosis by inhibiting tubular epithelial-mesenchymal transition in vivo and in vitro
Guang Shan et al.
EXPERIMENTAL AND THERAPEUTIC MEDICINE (2016)
Glycogen synthase kinase 3 in Wnt signaling pathway and cancer
Nydia Tejeda-Munoz et al.
IUBMB LIFE (2015)
Astragaloside IV Inhibits NF-kappa B Activation and Inflammatory Gene Expression in LPS-Treated Mice
Wei-Jian Zhang et al.
MEDIATORS OF INFLAMMATION (2015)
Wnt/β-catenin signalling and podocyte dysfunction in proteinuric kidney disease
Lili Zhou et al.
NATURE REVIEWS NEPHROLOGY (2015)
Sequential RAAS Blockade: Is It Worth the Risk?
Frederik Persson et al.
ADVANCES IN CHRONIC KIDNEY DISEASE (2014)
Astragaloside IV inhibits renal tubulointerstitial fibrosis by blocking TGF-β/Smad signaling pathway in vivo and in vitro
Li Wang et al.
EXPERIMENTAL BIOLOGY AND MEDICINE (2014)
DAVID-WS: a stateful web service to facilitate gene/protein list analysis
Xiaoli Jiao et al.
BIOINFORMATICS (2012)
Astragaloside IV, a Novel Antioxidant, Prevents Glucose-Induced Podocyte Apoptosis In Vitro and In Vivo
Dingkun Gui et al.
PLOS ONE (2012)
Mouse model of ischemic acute kidney injury: technical notes and tricks
Qingqing Wei et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2012)
Ligand docking and binding site analysis with PyMOL and Autodock/Vina
Daniel Seeliger et al.
JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN (2010)
TGF-β and fibrosis in different organs - molecular pathway imprints
Dirk Pohlers et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2009)
Activation of Erk1/2 and Akt following unilateral ureteral obstruction
Ana B. Rodriguez-Pena et al.
KIDNEY INTERNATIONAL (2008)
Type I transforming growth factor β receptor binds to and activates phosphatidylinositol 3-kinase
JY Yi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Share Paper
